Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 2, 2021
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
[ Tue, Mar 02nd 2021
] - WOPRAI
Mon, March 1, 2021
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
[ Mon, Mar 01st 2021
] - WOPRAI
Anupam Rama Downgraded (AGIO) to Hold and Held Target at $54 on, Mar 1st, 2021
Anupam Rama of JP Morgan, Downgraded "Agios Pharmaceuticals, Inc." (AGIO) to Hold and Held Target at $54 on, Mar 1st, 2021.
Anupam has made no other calls on AGIO in the last 4 months.
There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Berens of "SVB Leerink" Downgraded from Buy to Hold and Decreased Target to $50 on, Friday, February 26th, 2021
This is the rating of the analyst that currently disagrees with Anupam
- John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $57 on, Monday, December 28th, 2020
